Live Breaking News & Updates on Jeffrey stuart peters

Stay informed with the latest breaking news from Jeffrey stuart peters on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Jeffrey stuart peters and stay connected to the pulse of your community

MacroGenics (NASDAQ:MGNX) Shares Down 10.8%

MacroGenics (NASDAQ:MGNX) Shares Down 10.8%
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United-states , China , Jeffrey-stuart-peters , Sg-americas-securities , Income-strategies , Nasdaq , Sherbrooke-park-advisers , Macrogenics-inc , China-universal-asset-management-co , Get-free-report , Genics-stock-down , Stuart-peters

MacroGenics (NASDAQ:MGNX) Now Covered by Analysts at B. Riley

B. Riley initiated coverage on shares of MacroGenics (NASDAQ:MGNX – Free Report) in a research note published on Friday morning, Marketbeat Ratings reports. The brokerage issued a buy rating and a $25.00 price objective on the biopharmaceutical company’s stock. A number of other brokerages also recently issued reports on MGNX. TD Cowen raised shares of […]

Los-angeles , California , United-states , Massachusetts , Jeffrey-stuart-peters , Ezio-bonvini , Barclays , Los-angeles-capital-management , Massachusetts-financial-services-co , Macrogenics-company-profile , Securities-exchange-commission , Macrogenics-inc

JMP Securities Reiterates "Market Outperform" Rating for MacroGenics (NASDAQ:MGNX)

JMP Securities restated their market outperform rating on shares of MacroGenics (NASDAQ:MGNX – Free Report) in a research report report published on Thursday, Benzinga reports. A number of other research firms have also recently commented on MGNX. BTIG Research boosted their price target on shares of MacroGenics from $12.00 to $24.00 and gave the stock […]

United-states , Ezio-bonvini , Jeffrey-stuart-peters , Barclays , Group-plc , Exome-asset-management , Perceptive-advisors , Citigroup , Barclays-plc , Securities-exchange-commission , Macrogenics-inc , Free-report

GSA Capital Partners LLP Purchases 96,760 Shares of MacroGenics, Inc. (NASDAQ:MGNX)

GSA Capital Partners LLP increased its position in shares of MacroGenics, Inc. (NASDAQ:MGNX – Free Report) by 74.9% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 225,918 shares of the biopharmaceutical company’s stock after buying an additional 96,760 shares during the […]

United-states , Jeffrey-stuart-peters , Ezio-bonvini , Capital-partners , Macrogenics-company-profile , Tower-research-capital , Exchange-commission , Macrogenics-inc , Barclays , Sherbrooke-park-advisers , Securities-exchange-commission , Capital-management

MacroGenics (NASDAQ:MGNX) Upgraded to Buy by StockNews.com

StockNews.com upgraded shares of MacroGenics (NASDAQ:MGNX – Get Rating) from a hold rating to a buy rating in a research report report published on Friday. Several other analysts also recently commented on the company. Citigroup increased their price objective on MacroGenics from $7.00 to $8.00 in a research note on Monday, March 20th. Stifel Nicolaus […]

Stifel-nicolaus , Jeffrey-stuart-peters , Securities-exchange-commission , Hsbc-holdings , Macrogenics-company-profile , Citigroup , Macrogenics-inc , Get-rating , Moderate-buy , Genics-trading-down , Stuart-peters , Exchange-commission

MacroGenics (NASDAQ:MGNX) Price Target Raised to $10.00 at JMP Securities

MacroGenics (NASDAQ:MGNX – Get Rating) had its target price hoisted by JMP Securities from $8.00 to $10.00 in a research report sent to investors on Thursday morning, The Fly reports. MGNX has been the topic of a number of other research reports. Citigroup boosted their price target on shares of MacroGenics from $7.00 to $8.00 […]

Texas , United-states , Stifel-nicolaus , Jeffrey-stuart-peters , Zurcher-kantonalbank-zurich-cantonalbank , Ensign-peak-advisors-inc , Macrogenics-inc , Citigroup , Macrogenics-company-profile , Securities-exchange-commission , Nisa-investment-advisors , Get-rating

Q2 2023 EPS Estimates for MacroGenics, Inc. Cut by SVB Leerink (NASDAQ:MGNX)

MacroGenics, Inc. (NASDAQ:MGNX – Get Rating) – Investment analysts at SVB Leerink decreased their Q2 2023 EPS estimates for MacroGenics in a report issued on Tuesday, May 9th. SVB Leerink analyst J. Chang now expects that the biopharmaceutical company will earn ($0.71) per share for the quarter, down from their prior forecast of ($0.35). The […]

Texas , United-states , Jeffrey-stuart-peters , Zurcher-kantonalbank-zurich-cantonalbank , Stifel-nicolaus , Securities-exchange-commission , Nisa-investment-advisors , Nasdaq , Macrogenics-inc , Citigroup , Ensign-peak-advisors-inc , Get-rating

MacroGenics (NASDAQ:MGNX) Price Target Raised to $10.00

MacroGenics (NASDAQ:MGNX – Get Rating) had its price objective increased by equities research analysts at JMP Securities from $8.00 to $10.00 in a research note issued to investors on Thursday, The Fly reports. JMP Securities’ price target would indicate a potential upside of 38.70% from the stock’s previous close. Several other research firms have also […]

Zurcher-kantonalbank-zurich-cantonalbank , Stifel-nicolaus , Jeffrey-stuart-peters , Securities-exchange-commission , Macrogenics-company-profile , Commonwealth-equity-services , Allspring-global-investments-holdings , Nisa-investment-advisors , Nasdaq , Macrogenics-inc , Get-rating , Stuart-peters

Brokerages Set MacroGenics, Inc. (NASDAQ:MGNX) Target Price at $11.11

MacroGenics, Inc. (NASDAQ:MGNX – Get Rating) has received a consensus rating of “Moderate Buy” from the thirteen brokerages that are presently covering the company, Marketbeat reports. Five analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1 year price objective among brokers that […]

Texas , United-states , Jeffrey-stuart-peters , Stifel-nicolaus , Nisa-investment-advisors , Macrogenics-company-profile , Denali-advisors , Ensign-peak-advisors-inc , Nasdaq , Citigroup , Securities-exchange-commission , Macrogenics-inc

MacroGenics, Inc. Expected to Earn Q1 2023 Earnings of $1.44 Per Share (NASDAQ:MGNX)

MacroGenics, Inc. (NASDAQ:MGNX – Get Rating) – Analysts at HC Wainwright lifted their Q1 2023 earnings per share estimates for MacroGenics in a research report issued to clients and investors on Monday, April 3rd. HC Wainwright analyst R. Burns now forecasts that the biopharmaceutical company will post earnings of $1.44 per share for the quarter, […]

Switzerland , Swiss , Jeffrey-stuart-peters , Acadian-asset-management , Nasdaq , Vanguard-group-inc , Jpmorgan-chase-co , Swiss-national-bank , Citigroup , Securities-exchange-commission , Macrogenics-inc , Metlife-investment-management